These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2254874)

  • 21. Safer contrast agents?
    Dawson P; Allison DJ
    Br J Hosp Med; 1989 Nov; 42(5):406-7. PubMed ID: 2597825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Excretion of contrast media by the immature rabbit. Comparison of Renografin and Iopamidol.
    Rosenbaum DM; Caldicott WJ
    Invest Radiol; 1984; 19(2):123-8. PubMed ID: 6533102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What are radiologists doing to prevent contrast-induced nephropathy (CIN) compared with measures supported by current evidence? A survey of European radiologists on CIN associated with computed tomography.
    Fishman EK; Reddan D
    Acta Radiol; 2008 Apr; 49(3):310-20. PubMed ID: 18365820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Iodinated contrast media and nephropathy--new recommendations. Estimated creatine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Lakartidningen; 2003 Mar; 100(10):840-3, 846-8. PubMed ID: 12680021
    [No Abstract]   [Full Text] [Related]  

  • 25. Advantages of a low-osmolality ionic contrast medium in intra-arterial applications.
    Miller K
    Radiol Technol; 1987; 59(1):43-8. PubMed ID: 3659338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Contrast media-associated nephropathy--pathogenesis and prevention].
    Erley CM; Duda SH
    Aktuelle Radiol; 1997 Jul; 7(4):189-92. PubMed ID: 9340015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Contrast-induced nephropathy. Current concepts and propositions for Italian guidelines].
    Meschi M; Detrenis S; Savazzi G
    Recenti Prog Med; 2008 Mar; 99(3):155-62. PubMed ID: 18488528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Urography and renal clearance of contrast media. A randomized comparison of an ionic high-osmolar and a non-ionic low-osmolar contrast medium].
    Vestergaard AS; Thomsen HS
    Ugeskr Laeger; 1990 Jan; 152(3):154-7. PubMed ID: 2405555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iodinated contrast media and contrast-induced nephropathy: is there a preferred cost-effective agent?
    Sharma SK
    J Invasive Cardiol; 2008 May; 20(5):245-8. PubMed ID: 18460711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast medium use.
    Davidson C; Stacul F; McCullough PA; Tumlin J; Adam A; Lameire N; Becker CR;
    Am J Cardiol; 2006 Sep; 98(6A):42K-58K. PubMed ID: 16949380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nephrotoxicity of high- and low-osmolality contrast media.
    Jevnikar AM; Finnie KJ; Dennis B; Plummer DT; Avila A; Linton AL
    Nephron; 1988; 48(4):300-5. PubMed ID: 3362276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. For patients with renal insufficiency, do low-osmolar iodinated contrast agents lessen the risk of nephrotoxicity, compared with high-osmolar agents?
    Hopper KD
    AJR Am J Roentgenol; 1997 Jun; 168(6):1615. PubMed ID: 9168738
    [No Abstract]   [Full Text] [Related]  

  • 33. Low-osmolality versus high-osmolality contrast material.
    Korn WT; Bettmann MA
    Curr Opin Radiol; 1992 Apr; 4(2):9-15. PubMed ID: 1554592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure to demonstrate contrast nephrotoxicity.
    Heller CA; Knapp J; Halliday J; O'Connell D; Heller RF
    Med J Aust; 1991 Sep; 155(5):329-32. PubMed ID: 1895978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nephrotoxicity of low osmolality contrast media versus high osmolality media.
    Steinberg EP; Moore RD; Brinker JA; Fishman EK; Powe NR; Graziano SL; Gopalan R
    Invest Radiol; 1991 Nov; 26 Suppl 1():S86; discussion S88-91. PubMed ID: 1808157
    [No Abstract]   [Full Text] [Related]  

  • 36. Preston M. Hickey memorial lecture. Ionic and nonionic iodinated contrast media: evolution and strategies for use.
    McClennan BL
    AJR Am J Roentgenol; 1990 Aug; 155(2):225-33. PubMed ID: 2115244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis.
    Caro JJ; Trindade E; McGregor M
    AJR Am J Roentgenol; 1991 Apr; 156(4):825-32. PubMed ID: 1825900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative safety of high-osmolality and low-osmolality radiographic contrast agents.
    Lasser EC
    Invest Radiol; 1992 May; 27(5):397-9. PubMed ID: 1582825
    [No Abstract]   [Full Text] [Related]  

  • 39. [Iodinated contrast agents used in Radiology].
    Ramírez Ribelles C; Sánchez Fuster MA; Pamies Guilabert J
    Radiologia; 2014 Jun; 56 Suppl 1():12-20. PubMed ID: 25267147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is contrast medium osmolality a causal factor for contrast-induced nephropathy?
    Bucher AM; De Cecco CN; Schoepf UJ; Meinel FG; Krazinski AW; Spearman JV; McQuiston AD; Wang R; Bucher J; Vogl TJ; Katzberg RW
    Biomed Res Int; 2014; 2014():931413. PubMed ID: 24800254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.